Newsbenzinga
Top Wall Street Forecasters Revamp Eli Lilly Expectations Ahead Of Q3 Earnings
· Published
Article summary
Eli Lilly reports Q3 earnings Oct. 29; EPS is forecast at $6.67, revenue at $22.62B. New Omvoh data supports ulcerative colitis and Crohn’s treatment.
An excerpt from the original article.
Comments —
Loading comments…